Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 196

Results For "Act"

7985 News Found

Intelligent Bio Solutions taps Global MedTech giant Syrma Johari to scale production
Medical Device | January 04, 2026

Intelligent Bio Solutions taps Global MedTech giant Syrma Johari to scale production

Syrma Johari is a globally recognised medical device engineering and manufacturing organisation


Strides appoints Yajuvendra Singh M R as VP - Digital Transformation
People | January 04, 2026

Strides appoints Yajuvendra Singh M R as VP - Digital Transformation

Singh previously served as Head of IT (Development and Manufacturing Services) at Syngene International Limited, Lead of IT Manufacturing at UPL, and AGM at The Hi-Tech Gears


FibroBiologics moves experimental psoriasis therapy into FDA review
News | January 04, 2026

FibroBiologics moves experimental psoriasis therapy into FDA review

The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline


FDA nod to first new motion sickness drug in 40 years
Clinical Trials | January 04, 2026

FDA nod to first new motion sickness drug in 40 years

The approval is supported by data from three pivotal clinical trials


Elanco scores USDA nod for new canine allergy drug Befrena
News | January 04, 2026

Elanco scores USDA nod for new canine allergy drug Befrena

Elanco expects Befrena to launch in the US in the first half of 2026


Indian Pharmacopoeia 2026 debuts with 121 new monographs targeting TB, diabetes, and cancer
News | January 04, 2026

Indian Pharmacopoeia 2026 debuts with 121 new monographs targeting TB, diabetes, and cancer

Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes


Caplin Point Labs acquires 10 ANDAs, targets $473M US market
News | January 03, 2026

Caplin Point Labs acquires 10 ANDAs, targets $473M US market

The portfolio, purchased from a leading multinational generic manufacturer, addresses a market valued at $473.2 million for the 12 months ending August 2025


Biotium launches GlycoLiner kits for fast & selective cell surface glycoprotein labelling
News | January 03, 2026

Biotium launches GlycoLiner kits for fast & selective cell surface glycoprotein labelling

Biotium reports that GlycoLiner Labelling is fully covalent and compatible with standard fixation and permeabilization protocols


Cupid reports record Q3, eyes GCC expansion with Saudi FMCG facility
News | January 03, 2026

Cupid reports record Q3, eyes GCC expansion with Saudi FMCG facility

Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity


Savara resubmits FDA application for potential treatment in rare lung disease patients
Biopharma | January 01, 2026

Savara resubmits FDA application for potential treatment in rare lung disease patients

The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer